Paul A. Friedman
Chief Executive Officer, Incyte.
Companies
- Prelude Therapeutics IncBoard member Sep 24, 2020 to now1
- MADRIGAL PHARMACEUTICALS, INC.Board member Mar 5, 2014 to now2
- MADRIGAL PHARMACEUTICALS, INC.Chief executive officer Jul 26, 2016 to Jan 18, 20233
- Alexion PharmaceuticalsBoard member Sep 22, 2017 to Jul 23, 20214
- IncyteBoard member Jan 17, 2006 to May 28, 20205
- Dare Bioscience, Inc.Board member Apr 10, 2014 to Apr 5, 20176
- Verastem OncologyBoard member May 13, 2014 to Jun 16, 20167
- IncyteChief executive officer Jan 17, 2006 to Dec 20, 20135
- Bausch & LombBoard member Sep 25, 2007 to Oct 30, 20078
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARIncyte, Board member
- 6SEC EDGARDare Bioscience, Inc., Board member
- 7SEC EDGARVerastem Oncology, Board member
- 8SEC EDGARBausch & Lomb, Board member